Darren Wall, on May 30, 2024 9:00:00 AM
High-growth tech investments are attracting interest from experts worldwide thanks to the future prospects of this sector. S&P forecast statistics for 2024 indicate that the tech segment will likely grow by 29% in earnings. By 2025, this percentage is expected to reach the 17% mark. If you’ve been considering investing in high-growth tech companies, this is a great time to scout around for options.
Isaac Smith, on May 29, 2024 6:00:00 AM
The impact of venture capital on healthcare innovation is clear. VC-backed companies have pioneered healthcare innovations in the past decade and are revolutionizing healthcare with new cancer and rare disease treatments, medical device innovations, and digital health.
Darren Wall, on May 21, 2024 6:11:13 AM
Progentos Therapeutics announced that it has successfully raised $65 million in a Series A funding round. Progentos is a Boston-based startup with the mission of developing groundbreaking treatments for diseases that affect nerve cells, such as Multiple Sclerosis (MS) and other demyelinating diseases.
Darren Wall, on May 16, 2024 3:58:17 PM
According to KPMG's new Venture Pulse report, global Venture Capital (VC) investment plummeted to $75.9 billion across 7,520 deals in Q1 of 2024. This decline is attributed to geopolitical tensions, a lack of market exits, and a discernible reduction in investment during the later deal stages. This article will analyze key trends from Q1 2024 data and provide actionable insights for VCs navigating the evolving landscape.
